BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 12544246)

  • 1. Evaluation of hemangioma by positron emission tomography: role in a multimodality approach.
    Hatayama K; Watanabe H; Ahmed AR; Yanagawa T; Shinozaki T; Oriuchi N; Aoki J; Takeuchi K; Endo K; Takagishi K
    J Comput Assist Tomogr; 2003; 27(1):70-7. PubMed ID: 12544246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Schwannoma of the extremities: the role of PET in preoperative planning.
    Ahmed AR; Watanabe H; Aoki J; Shinozaki T; Takagishi K
    Eur J Nucl Med; 2001 Oct; 28(10):1541-51. PubMed ID: 11685498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PET imaging of musculoskeletal tumours with fluorine-18 alpha-methyltyrosine: comparison with fluorine-18 fluorodeoxyglucose PET.
    Watanabe H; Inoue T; Shinozaki T; Yanagawa T; Ahmed AR; Tomiyoshi K; Oriuchi N; Tokunaga M; Aoki J; Endo K; Takagishi K
    Eur J Nucl Med; 2000 Oct; 27(10):1509-17. PubMed ID: 11083540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carbon-11 choline positron emission tomography in musculoskeletal tumors: comparison with fluorine-18 fluorodeoxyglucose positron emission tomography.
    Yanagawa T; Watanabe H; Inoue T; Ahmed AR; Tomiyoshi K; Shinozaki T; Oriuchi N; Endo K; Takagishi K
    J Comput Assist Tomogr; 2003; 27(2):175-82. PubMed ID: 12703009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thoracic hemangiomas: imaging via CT, MR, and PET along with pathologic correlation.
    Sakurai K; Hara M; Ozawa Y; Nakagawa M; Shibamoto Y
    J Thorac Imaging; 2008 May; 23(2):114-20. PubMed ID: 18520569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PET evaluation of fatty tumors in the extremity: possibility of using the standardized uptake value (SUV) to differentiate benign tumors from liposarcoma.
    Suzuki R; Watanabe H; Yanagawa T; Sato J; Shinozaki T; Suzuki H; Endo K; Takagishi K
    Ann Nucl Med; 2005 Dec; 19(8):661-70. PubMed ID: 16444991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imaging strategies in the evaluation of soft-tissue hemangiomas of the extremities: correlation of the findings of plain radiography, angiography, CT, MRI, and ultrasonography in 12 histologically proven cases.
    Greenspan A; McGahan JP; Vogelsang P; Szabo RM
    Skeletal Radiol; 1992; 21(1):11-8. PubMed ID: 1546331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis of maxillofacial tumor with L-3-[18f]-fluoro-alpha-methyltyrosine (FMT) PET: a comparative study with FDG-PET.
    Miyakubo M; Oriuchi N; Tsushima Y; Higuchi T; Koyama K; Arai K; Paudyal B; Iida Y; Hanaoka H; Ishikita T; Nakasone Y; Negishi A; Mogi K; Endo K
    Ann Nucl Med; 2007 Feb; 21(2):129-35. PubMed ID: 17424980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cavernous hemangioma of the ilium mimicking aggressive malignant bone tumor with increased activity on (18)F-FDG PET/CT.
    Ko SW; Park JG
    Korean J Radiol; 2013; 14(2):294-8. PubMed ID: 23482507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synovial hemangioma: imaging features in eight histologically proven cases, review of the literature, and differential diagnosis.
    Greenspan A; Azouz EM; Matthews J; Décarie JC
    Skeletal Radiol; 1995 Nov; 24(8):583-90. PubMed ID: 8614857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance of whole-body integrated 18F-FDG PET/MR in comparison to PET/CT for evaluation of malignant bone lesions.
    Eiber M; Takei T; Souvatzoglou M; Mayerhoefer ME; Fürst S; Gaertner FC; Loeffelbein DJ; Rummeny EJ; Ziegler SI; Schwaiger M; Beer AJ
    J Nucl Med; 2014 Feb; 55(2):191-7. PubMed ID: 24309383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic usefulness of fluorine-18-alpha-methyltyrosine positron emission tomography in combination with 18F-fluorodeoxyglucose in sarcoidosis patients.
    Kaira K; Oriuchi N; Otani Y; Yanagitani N; Sunaga N; Hisada T; Ishizuka T; Endo K; Mori M
    Chest; 2007 Apr; 131(4):1019-27. PubMed ID: 17426205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2-[Fluorine-18]-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography versus whole-body diffusion-weighted MRI for detection of malignant lesions: initial experience.
    Komori T; Narabayashi I; Matsumura K; Matsuki M; Akagi H; Ogura Y; Aga F; Adachi I
    Ann Nucl Med; 2007 Jun; 21(4):209-15. PubMed ID: 17581719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positron emission tomography imaging of musculoskeletal tumors in the shoulder girdle.
    Suzuki H; Watanabe H; Shinozaki T; Yanagawa T; Suzuki R; Takagishi K
    J Shoulder Elbow Surg; 2004; 13(6):635-47. PubMed ID: 15570232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of simultaneously acquired diffusion-weighted imaging and 2-deoxy-[18F] fluoro-2-D-glucose positron emission tomography of pulmonary lesions in a dedicated whole-body magnetic resonance/positron emission tomography system.
    Schmidt H; Brendle C; Schraml C; Martirosian P; Bezrukov I; Hetzel J; Müller M; Sauter A; Claussen CD; Pfannenberg C; Schwenzer NF
    Invest Radiol; 2013 May; 48(5):247-55. PubMed ID: 23519008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retrospective review: usefulness of a number of imaging modalities including CT, MRI, technetium-99m pertechnetate scintigraphy, gallium-67 scintigraphy and F-18-FDG PET in the differentiation of benign from malignant parotid masses.
    Ozawa N; Okamura T; Koyama K; Nakayama K; Kawabe J; Shiomi S; Yamane H; Inoue Y
    Radiat Med; 2006 Jan; 24(1):41-9. PubMed ID: 16715661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive Oncologic Imaging in Infants and Preschool Children With Substantially Reduced Radiation Exposure Using Combined Simultaneous ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging: A Direct Comparison to ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.
    Gatidis S; Schmidt H; Gücke B; Bezrukov I; Seitz G; Ebinger M; Reimold M; Pfannenberg CA; Nikolaou K; Schwenzer NF; Schäfer JF
    Invest Radiol; 2016 Jan; 51(1):7-14. PubMed ID: 26309185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic performance of
    Chaput A; Robin P; Podeur F; Ollivier M; Keromnes N; Tissot V; Nonent M; Salaün PY; Rousset J; Abgral R
    Laryngoscope; 2018 Feb; 128(2):378-385. PubMed ID: 28600822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. F18-fluorodeoxyglucose positron emission tomography/computed tomography in the evaluation of vertebral vascular tumors.
    Song L; Han S; Jiang L; Zhang W
    Clin Imaging; 2020 Sep; 65():24-32. PubMed ID: 32353715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.